WS #16357
The White House signed an executive order addressing housing costs, a rare direct intervention in domestic inflation metrics that may temporarily dampen rate-cut expectations. In biotech, Moderna remains under pressure after a 24% intraday drop triggered by a cancer vaccine data leak, with traders exiting put positions to limit losses. Meanwhile, unusual options activity in the QQQ ETF suggests institutional investors are buying December puts to hedge against broader market volatility.
Domestic Policy and Biotech Volatility
The White House signed an executive order addressing housing costs, a rare direct intervention in domestic inflation metrics that may temporarily dampen rate-cut expectations. In biotech, Moderna remains under pressure after a 24% intraday drop triggered by a cancer vaccine data leak, with traders exiting put positions to limit losses. Meanwhile, unusual options activity in the QQQ ETF suggests institutional investors are buying December puts to hedge against broader market volatility.